Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Nov;68(5):1366–1369. doi: 10.1172/JCI110384

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

P D Henry, K I Bentley
PMCID: PMC370933  PMID: 7298856

Abstract

We tested the effects of nifedipine, a calcium antagonist, on atherogenesis in rabbits fed a 2% cholesterol diet. The drug was given orally, 40 mg/dl, and control rabbits received placebo. Nifedipine was well tolerated, and evoked only transient, moderate reductions in arterial pressure. Plasma total cholesterol after 8 wk before killing the rabbits was similar in the placebo and nifedipine-treated groups, averaging 1,903 +/- 138 (n = 13) and 1,848 +/- 121 mg/dl (n = 13; mean +/- SE; P greater than 0.8). In placebo-treated rabbits, aortic lesions stainable with Sudan IV covered 40 +/- 5% of the intimal surface, and the cholesterol concentration in aortic tissue was 47 +/- 5 mg/g protein. Corresponding values for the aortas from nifedipine-treated rabbits were significantly lower and averaged 17 +/- 3% (P less than 0.001) and 29 +/- 2 mg/g protein (P less than 0.001). We conclude that nifedipine suppressed atherogenesis without reducing hypercholesterolemia.

Full text

PDF
1366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackmore P. F., El-Refai M. F., Exton J. H. alpha-Adrenergic blockade and inhibition of A23187 mediated Ca2+ uptake by the calcium antagonist verapamil in rat liver cells. Mol Pharmacol. 1979 May;15(3):598–606. [PubMed] [Google Scholar]
  2. Blumenthal H. T., Lansing A. I., Wheeler P. A. Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease. Am J Pathol. 1944 Jul;20(4):665–687. [PMC free article] [PubMed] [Google Scholar]
  3. Bretherton K. N., Day A. J., Skinner S. L. Hypertension-accelerated atherogenesis in cholesterol-fed rabbits. Atherosclerosis. 1977 May;27(1):79–87. doi: 10.1016/0021-9150(77)90027-2. [DOI] [PubMed] [Google Scholar]
  4. Britt B. A. Etiology and pathophysiology of malignant hyperthermia. Fed Proc. 1979 Jan;38(1):44–48. [PubMed] [Google Scholar]
  5. Chan C. T., Wells H., Kramsch D. M. Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. The effect of thiophene compounds. Circ Res. 1978 Jul;43(1):115–125. doi: 10.1161/01.res.43.1.115. [DOI] [PubMed] [Google Scholar]
  6. HOLMAN R. L., McGILL H. C., Jr, STRONG J. P., GEER J. C. Technics for studying atherosclerotic lesions. Lab Invest. 1958 Jan-Feb;7(1):42–47. [PubMed] [Google Scholar]
  7. Heistad D. D., Armstrong M. L., Marcus M. L. Hyperemia of the aortic wall in atherosclerotic monkeys. Circ Res. 1981 May;48(5):669–675. doi: 10.1161/01.res.48.5.669. [DOI] [PubMed] [Google Scholar]
  8. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  9. Henry P. D., Schuchleib R., Davis J., Weiss E. S., Sobel B. E. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol. 1977 Dec;233(6):H677–H684. doi: 10.1152/ajpheart.1977.233.6.H677. [DOI] [PubMed] [Google Scholar]
  10. Hollander W., Paddock J., Nagraj S., Colombo M., Kirkpatrick B. Effects of anticalcifying and antifibrobrotic drugs on pre-established atherosclerosis in the rabbit. Atherosclerosis. 1979 May;33(1):111–123. doi: 10.1016/0021-9150(79)90202-8. [DOI] [PubMed] [Google Scholar]
  11. Jasmin G., Solymoss B. Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents. Proc Soc Exp Biol Med. 1975 May;149(1):193–198. doi: 10.3181/00379727-149-38771. [DOI] [PubMed] [Google Scholar]
  12. Kramsch D. M., Chan C. T. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Circ Res. 1978 Apr;42(4):562–571. doi: 10.1161/01.res.42.4.562. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Potokar M., Schmidt-Dunker M. The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo. Atherosclerosis. 1978 Aug;30(4):313–320. doi: 10.1016/0021-9150(78)90124-7. [DOI] [PubMed] [Google Scholar]
  15. Publicover S. J., Duncan C. J., Smith J. L. The use of A23187 to demonstrate the role of intracellular calcium in causing ultrastructural damage in mammalian muscle. J Neuropathol Exp Neurol. 1978 Sep;37(5):554–557. [PubMed] [Google Scholar]
  16. Rosenblum I. Y., Flora L., Eisenstein R. The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. Atherosclerosis. 1975 Nov-Dec;22(3):411–424. doi: 10.1016/0021-9150(75)90021-0. [DOI] [PubMed] [Google Scholar]
  17. Schanne F. A., Kane A. B., Young E. E., Farber J. L. Calcium dependence of toxic cell death: a final common pathway. Science. 1979 Nov 9;206(4419):700–702. doi: 10.1126/science.386513. [DOI] [PubMed] [Google Scholar]
  18. Stary H. C. Arterial cell injury and cell death in hypercholesterolemia and after reduction of high serum cholesterol levels. Prog Biochem Pharmacol. 1977;13:241–247. [PubMed] [Google Scholar]
  19. Thomas W. A., Imai H., Florentin R. A., Reiner J. M., Scott R. F. Smooth muscle and endothelial cell deaths in atherogenesis studied by autoradiography. Prog Biochem Pharmacol. 1977;13:234–240. [PubMed] [Google Scholar]
  20. Vater W., Kroneberg G., Hoffmeister F., Saller H., Meng K., Oberdorf A., Puls W., Schlossmann K., Stoepel K. Zur Pharmakologie von 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine), BAY a 1040. Arzneimittelforschung. 1972 Jan;22(1):1–14. [PubMed] [Google Scholar]
  21. Wartman A., Lampe T. L., McCann D. S., Boyle A. J. Plaque reversal with MgEDTA in experimental atherosclerosis: elastin and collagen metabolism. J Atheroscler Res. 1967 May-Jun;7(3):331–341. doi: 10.1016/s0368-1319(67)80060-7. [DOI] [PubMed] [Google Scholar]
  22. Wrogemann K., Pena S. D. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet. 1976 Mar 27;1(7961):672–674. doi: 10.1016/s0140-6736(76)92781-1. [DOI] [PubMed] [Google Scholar]
  23. Yokoyama M., Henry P. D. Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res. 1979 Oct;45(4):479–486. doi: 10.1161/01.res.45.4.479. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES